Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Cell Host Microbe ; 20(2): 215-25, 2016 Aug 10.
Artículo en Inglés | MEDLINE | ID: mdl-27512904

RESUMEN

Fusobacterium nucleatum is associated with colorectal cancer and promotes colonic tumor formation in preclinical models. However, fusobacteria are core members of the human oral microbiome and less prevalent in the healthy gut, raising questions about how fusobacteria localize to CRC. We identify a host polysaccharide and fusobacterial lectin that explicates fusobacteria abundance in CRC. Gal-GalNAc, which is overexpressed in CRC, is recognized by fusobacterial Fap2, which functions as a Gal-GalNAc lectin. F. nucleatum binding to clinical adenocarcinomas correlates with Gal-GalNAc expression and is reduced upon O-glycanase treatment. Clinical fusobacteria strains naturally lacking Fap2 or inactivated Fap2 mutants show reduced binding to Gal-GalNAc-expressing CRC cells and established CRCs in mice. Additionally, intravenously injected F. nucleatum localizes to mouse tumor tissues in a Fap2-dependent manner, suggesting that fusobacteria use a hematogenous route to reach colon adenocarcinomas. Thus, targeting F. nucleatum Fap2 or host epithelial Gal-GalNAc may reduce fusobacteria potentiation of CRC.


Asunto(s)
Adenocarcinoma/patología , Adhesinas Bacterianas/metabolismo , Antígenos de Carbohidratos Asociados a Tumores/metabolismo , Adhesión Bacteriana , Neoplasias del Colon/patología , Fusobacterium nucleatum/fisiología , Lectinas/metabolismo , Adenocarcinoma/microbiología , Animales , Línea Celular Tumoral , Neoplasias del Colon/microbiología , Modelos Animales de Enfermedad , Células Epiteliales/metabolismo , Células Epiteliales/microbiología , Interacciones Huésped-Patógeno , Humanos , Ratones Endogámicos BALB C , Modelos Biológicos , Unión Proteica
2.
FEMS Microbiol Lett ; 248(2): 235-40, 2005 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-15993010

RESUMEN

Fusobacterium nucleatum is a common oral anaerobe associated with gingivitis, periodontal disease and preterm deliveries. Coaggregation among oral bacteria is considered to be a significant factor in dental plaque development. Adhesion to host cells was suggested to be important for the F. nucleatum virulence associated with oral inflammation and with preterm births. An uncharacterized fusobacterial galactose inhibitible adhesin mediates coaggregation of F. nucleatum 12230 and F. nucleatum PK1594 with the periodontal pathogen Porphyromonas gingivalis. This adhesin is also involved with the attachment of both fusobacterial strains to host cells. However, it has been suggested that additional unidentified fusobacterial adhesins are involved in F. nucleatum virulence associated with preterm births. In this study, a fluorescence-based high throughput sensitive and reproducible method was developed for measuring bacterial coaggregation and bacterial attachment to mammalian cells. Using this method we found that coaggregation of F. nucleatum 4H with P. gingivalis and its attachment to murine macrophages is less inhibitible by galactose than that of F. nucleatum PK1594. These findings suggest that F. nucleatum 4H can serve as a model organism for identifying nongalactose inhibitible F. nucleatum adhesins considered to be involved in fusobacterial attachment to mammalian cells.


Asunto(s)
Fusobacterium nucleatum/fisiología , Animales , Adhesión Bacteriana/efectos de los fármacos , Técnicas Bacteriológicas/métodos , Línea Celular , Placa Dental/microbiología , Fluorescencia , Galactosa/farmacología , Macrófagos/microbiología , Ratones
3.
PLoS One ; 9(10): e111329, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25357190

RESUMEN

Fusobacterium nucleatum is an oral anaerobe associated with periodontal disease, adverse pregnancy outcomes and colorectal carcinoma. A serine endopeptidase of 61-65 kDa capable of damaging host tissue and of inactivating immune effectors was detected previously in F. nucleatum. Here we describe the identification of this serine protease, named fusolisin, in three oral F. nucleatum sub-species. Gel zymogram revealed fusobacterial proteolytic activity with molecular masses ranging from 55-101 kDa. All of the detected proteases were inhibited by the serine protease inhibitor PMSF. analysis revealed that all of the detected proteases are encoded by genes encoding an open reading frame (ORF) with a calculated mass of approximately 115 kDa. Bioinformatics analysis of the identified ORFs demonstrated that they consist of three domains characteristic of autotransporters of the type Va secretion system. Our results suggest that the F. nucleatum fusolisins are derived from a precursor of approximately 115 kDa. After crossing the cytoplasmic membrane and cleavage of the leader sequence, the C-terminal autotransporter domain of the remaining 96-113 kDa protein is embedded in the outer membrane and delivers the N-terminal S8 serine protease passenger domain to the outer cell surface. In most strains the N-terminal catalytic 55-65 kDa domain self cleaves and liberates itself from the autotransporter domain after its transfer across the outer cell membrane. In F. nucleatum ATCC 25586 this autocatalytic activity is less efficient resulting in a full length membrane-anchored serine protease. The mature serine protease was found to cleave after Thr, Gly, Ala and Leu residues at the P1 position. Growth of F. nucleatum in complex medium was inhibited when serine protease inhibitors were used. Additional experiments are needed to determine whether fusolisin might be used as a target for controlling fusobacterial infections.


Asunto(s)
Proteínas Bacterianas/metabolismo , Fusobacterium nucleatum/enzimología , Serina Proteasas/metabolismo , Sistemas de Secreción Tipo V/metabolismo , Secuencia de Aminoácidos , Proteínas Bacterianas/química , Fusobacterium nucleatum/crecimiento & desarrollo , Humanos , Hidrólisis , Datos de Secuencia Molecular , Peso Molecular , Proteolisis/efectos de los fármacos , Alineación de Secuencia , Análisis de Secuencia de Proteína , Serina Proteasas/química , Especificidad por Sustrato/efectos de los fármacos , Factores de Tiempo , Compuestos de Tosilo/farmacología , Sistemas de Secreción Tipo V/química
4.
Cell Host Microbe ; 14(6): 664-74, 2013 Dec 11.
Artículo en Inglés | MEDLINE | ID: mdl-24331464

RESUMEN

Uropathogenic Escherichia coli (UPEC) are a common cause of urinary tract infections (UTIs) in humans. While the importance of natural killer (NK) cells in innate immune protection against tumors and viral infections is well documented, their role in defense against bacterial infections is still emerging, and their involvement in UPEC-mediated UTI is practically unknown. Using a systematic mutagenesis approach, we found that UPEC adheres to NK cells primarily via its type I fimbriae and employs its hemolysinA toxin to kill NK cells. In the absence of hemolysinA, NK cells directly respond to the bacteria and secrete the cytokine TNF-α, which results in decreased bacterial numbers in vitro and reduction of bacterial burden in the infected bladders. Thus, NK cells control UPEC via TNF-α production, which UPEC counteracts by hemolysinA-mediated killing of NK cells, representing a previously unrecognized host defense and microbial counterattack mechanism in the context of UTI.


Asunto(s)
Proteínas de Escherichia coli/metabolismo , Proteínas Hemolisinas/metabolismo , Interacciones Huésped-Patógeno , Células Asesinas Naturales/inmunología , Células Asesinas Naturales/fisiología , Escherichia coli Uropatógena/inmunología , Escherichia coli Uropatógena/fisiología , Factores de Virulencia/metabolismo , Animales , Carga Bacteriana , Supervivencia Celular , Células Cultivadas , Elementos Transponibles de ADN , Proteínas de Escherichia coli/genética , Técnicas de Inactivación de Genes , Proteínas Hemolisinas/genética , Humanos , Ratones , Ratones Endogámicos C57BL , Mutagénesis Insercional , Factor de Necrosis Tumoral alfa/inmunología , Escherichia coli Uropatógena/patogenicidad , Factores de Virulencia/genética
5.
J Med Food ; 14(11): 1338-43, 2011 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-21548800

RESUMEN

Garlic has been used medicinally throughout human history. Allicin is considered the most therapeutic constituent of garlic. This study tested the antimicrobial activity of garlic allicin on oral pathogens associated with dental caries and periodontitis. Allicin was found effective against all the tested bacteria. The broth dilution method revealed that planktonic growth of the cariogenic, gram-positive species Streptococcus mutans, S. sobrinus, and Actinomyces oris was inhibited by an allicin concentration of 600 µg/mL or higher. Planktonic growth of the tested gram-negative periopathogenic species Aggregatibacter actinomycetemcomitans and Fusobacterium nucleatum was inhibited by a minimum allicin concentration of 300 µg/mL. Porphyromonas gingivalis, an anaerobic, gram-negative pathogen and the bacterium most associated with chronic periodontitis, demonstrated the lowest sensitivity to allicin (2,400 µg/mL). Gel zymography and the synthetic chromogenic substrate N(α)-benzoyl-L-arginine 4-nitroanilide hydrochloride demonstrated that allicin inhibits the proteases of P. gingivalis, including the arginine and lysine gingipains known as major virulence factors of this organism. A gingipain-inactivated mutant demonstrated high sensitivity to allicin (<300 µg/mL), revealing that gingipains confer resistance to allicin. Live/dead staining followed by analysis with confocal laser scanning microscopy revealed that allicin was bactericidal to S. mutans grown in mature biofilms. However, this bactericidal effect was reduced as biofilm depth increased. In conclusion, these results support the traditional medicinal use of garlic and suggest the use of allicin for alleviating dental diseases.


Asunto(s)
Antiinfecciosos/farmacología , Biopelículas/efectos de los fármacos , Extractos Vegetales/farmacología , Streptococcus mutans/efectos de los fármacos , Ácidos Sulfínicos/farmacología , Adhesinas Bacterianas/metabolismo , Aggregatibacter actinomycetemcomitans/efectos de los fármacos , Aggregatibacter actinomycetemcomitans/crecimiento & desarrollo , Aggregatibacter actinomycetemcomitans/patogenicidad , Arginina/metabolismo , Cisteína Endopeptidasas/metabolismo , Caries Dental/microbiología , Disulfuros , Relación Dosis-Respuesta a Droga , Fusobacterium nucleatum/efectos de los fármacos , Fusobacterium nucleatum/crecimiento & desarrollo , Fusobacterium nucleatum/patogenicidad , Ajo/química , Cisteína-Endopeptidasas Gingipaínas , Lisina/metabolismo , Pruebas de Sensibilidad Microbiana , Microscopía Confocal , Porphyromonas gingivalis/efectos de los fármacos , Porphyromonas gingivalis/crecimiento & desarrollo , Porphyromonas gingivalis/patogenicidad , Streptococcus mutans/crecimiento & desarrollo , Streptococcus mutans/patogenicidad
6.
ASDC J Dent Child ; 69(2): 133-7, 123, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12515053

RESUMEN

The present study compares periodontal parameters, caries, and levels of colony forming units (CFU) of bacteria from subgingival plaque of permanent teeth, to those of primary teeth examined 4 years previously. Six children who had periodontitis and 5 who had no periodontitis in primary teeth (groups A and B respectively) were examined. The microbial examination included the number of CFU of the total anaerobic count, Actinobacillus actinomycetemcomitans, Streptococcus mutans and Porphyromonas gingivalis. The differences in CFU values for the permanent teeth between groups A and B were not significant. Group A had significantly higher gingival inflammation values in the permanent teeth than group B. Permanent teeth had significantly higher CFU values of P. gingivalis than the primary teeth. Based on the present limited sample, the number of CFU from bacteria of the subgingival plaque of primary teeth are not an adequate predictor of periodontal disease or caries in the permanent teeth.


Asunto(s)
Periodontitis Agresiva/epidemiología , Caries Dental/epidemiología , Placa Dental/microbiología , Adolescente , Bacterias Anaerobias/aislamiento & purificación , Distribución de Chi-Cuadrado , Niño , Recuento de Colonia Microbiana , Dentición Permanente , Femenino , Humanos , Estudios Longitudinales , Masculino , Índice Periodontal , Factores de Riesgo , Diente Primario
7.
Appl Environ Microbiol ; 70(12): 6957-62, 2004 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-15574887

RESUMEN

Fusobacterium nucleatum is an important oral anaerobic pathogen involved in periodontal and systemic infections. Studies of the molecular mechanisms involved in fusobacterial virulence and adhesion have been limited by lack of systems for efficient genetic manipulation. Plasmids were isolated from eight strains of F. nucleatum. The smallest plasmid, pKH9 (4,975 bp), was characterized and used to create new vectors for fusobacterial genetic manipulation. DNA sequence analysis of pKH9 revealed an open reading frame (ORF) encoding a putative autonomous rolling circle replication protein (Rep), an ORF predicted to encode a protein homologous to members of the FtsK/SpoIIIE cell division-DNA segregation protein family, and an operon encoding a putative toxin-antitoxin plasmid addiction system (txf-axf). Deletion analysis localized the pKH9 replication region in a 0.96-kbp fragment. The pKH9 rep gene is not present in this fragment, suggesting that pKH9 can replicate in fusobacteria independently of the Rep protein. A pKH9-based, compact Escherichia coli-F. nucleatum shuttle plasmid was constructed and found to be compatible with a previously described pFN1-based fusobacterial shuttle plasmid. Deletion of the pKH9 putative addiction system (txf-axf) reduced plasmid stability in fusobacteria, indicating its addiction properties and suggesting it to be the first plasmid addiction system described for fusobacteria. pKH9, its genetic elements, and its shuttle plasmid derivatives can serve as useful tools for investigating fusobacterial properties important in biofilm ecology and pathogenesis.


Asunto(s)
Proteínas Bacterianas/genética , Toxinas Bacterianas/antagonistas & inhibidores , Fusobacterium nucleatum/genética , Plásmidos , Secuencias de Aminoácidos , Proteínas Bacterianas/química , Toxinas Bacterianas/genética , Secuencia de Bases , Replicación del ADN , Proteínas de Escherichia coli , Proteínas de la Membrana/química , Proteínas de la Membrana/genética , Datos de Secuencia Molecular , Sistemas de Lectura Abierta , Análisis de Secuencia de ADN
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA